Ann: First-in-human Study Progress Update, page-65

I was really hoping that the announcement would state the accuracy of detecting lymph node involvement ie nanoparticle detection v's biopsy/resection. So many more questions here, like has there been a patient been given a negative lymph node involvement following biopsy/resection but the nanoparticles have indicated on scanning that there is node involvement. It's all right and good just to say that the nanoparticles have reached the lymph nodes but is it 100% reaching them in all lymph node positive patients. Company really needs to clarify this.
The announcement is very short on specific details here. All comparison data should have been included. This is what gives shareholders the shits. Shareholders are very short changed on full comprehensive data.